充值vip 上传试卷赚钱
快速导航
学历类
职业资格
公务员
医卫类
建筑工程
外语类
外贸类
计算机类
财会类
技能鉴定
特种作业
安全生产
医疗药物
交通相关
科技类
食品类
服务行业
健康护理
其他类
当前位置：考试网  > 试卷库  > 职业资格  > 新闻媒体考试  > 广播电视播音员主持人  > 广播电视基础知识  > 简述新闻真实性原则的要求。
试题预览

简述新闻真实性原则的要求。

查看答案
收藏
纠错
正确答案：
答案解析：
上一题 下一题
你可能感兴趣的试题

结合实际，谈谈综艺娱乐类节目主持人应满足哪些专业要求。

查看答案

新闻工作党性原则的基本要求是什么?

查看答案

艺术作品的基本要求是

查看答案

《红与黑》的作者是()。

查看答案

广播电视即兴口语创作坚持准确性的原则，就是指（）。

①要用最恰当的字句，恰如其分、恰到好处地表现客观事物、表达思想感情;

②用老百姓原生态的语言来进行表达，准确就是要还原生活;

③口语表达中要掌握丰富的词汇，要会恰当地选择词语进行传播;

④汉语的词汇是相当丰富的，同是表示一种情态，同义词就可能多达几个甚至几十个，用哪一个都能让人听懂。

查看答案
热门试题 更多>
严厉惩处违反交规的人是良好交通秩序的保证。
试题分类： 口语
练习次数：0次
We regret that we are unable to meet your requirement for the time being as orders have been fully booked.
试题分类： 口语
练习次数：0次
性能测试包含了哪些软件测试(至少举出 3 种)?简述使用软件测试工具 Loadrunner 的步骤。
试题分类： 计算机四级
练习次数：0次
In order to extend our export business to your country we wish to enter into direct business relations with you.
试题分类： 口语
练习次数：0次
简要说明事务的原子性。
试题分类： 计算机二级
练习次数：0次
1.The failure of a high-profile cholesterol drug has thrown a spotlight on the complicated machinery that regulates cholesterol levels.But many researchers remain confident that drugs to boost levels of 'good' cholesterol are still one of the most promising means to combat spiralling heart disease. 2.Drug company Pfizer announced on 2 December that it was cancelling all clinical trials of torcetrapib，a drug designed to raise heart-protective high-density lipoproteins (HDLs).In a trial of 15000 patients，a safety board found that more people died or suffered cardiovascular problems after taking the drug plus a cholesterol-lowering statin than those in a control group who took the statin alone. 3.The news came as a kick in the teeth to many cardiologists because earlier tests in animals and people suggested it would lower rates of cardiovascular disease."There have been no red flags to my knowledge," says John Chapman，a specialist in lipoproteins and atherosclerosis at the National Institute for Health and Medical Research (INSERM) in Paris who has also studied torcetrapib."This cancellation came as a complete shock." 4.Torcetrapib is one of the most advanced of a new breed of drugs designed to raise levels of HDLs，which ferry cholesterol out of artery-clogging plaques to the liver for removal from the body.Specifically，torcetrapib blocks a protein called cholesterol ester transfer protein (CETP)，which normally transfers the cholesterol from high-density lipoproteins to low density，plaque-promoting ones.Statins，in contrast，mainly work by lowering the 'bad' low-density lipoproteins. Under pressure 5.Researchers are now trying to work out why and how the drug backfired，something that will not become clear until the clinical details are released by Pfizer.One hint lies in evidence from earlier trials that it slightly raises blood pressure in some patients.It was thought that this mild problem would be offset by the heart benefits of the drug.But it is possible that it actually proved fatal in some patients who already suffered high blood pressure.If blood pressure is the explanation，it would actually be good news for drug developers because it suggests that the problems are specific to this compound.Other prototype drugs that are being developed to block CETP work in a slightly different way and might not suffer the same downfall. 6.But it is also possible that the whole idea of blocking CETP is flawed，says Moti Kashyap，who directs atherosclerosis research at the VA Medical Center in Long Beach，California.When HDLs excrete cholesterol in the liver，they actually rely on LDLs for part of this process.So inhibiting CETP，which prevents the transfer of cholesterol from HDL to LDL，might actually cause an abnormal and irreversible accumulation of cholesterol in the body."You're blocking a physiologic mechanism to eliminate cholesterol and effectively constipating the pathway," says Kashyap.Going up 7.Most researchers remain confident that elevating high density lipoproteins levels by one means or another is one of the best routes for helping heart disease patients.But HDLs are complex and not entirely understood.One approved drug，called niacin，is known to both raise HDL and reduce cardiovascular risk but also causes an unpleasant sensation of heat and tingling.Researchers are exploring whether they can bypass this side effect and whether niacin can lower disease risk more than statins alone.Scientists are also working on several other means to bump up high-density lipoproteins by，for example，introducing synthetic HDLs."The only thing we know is dead in the water is torcetrapib，not the whole idea of raising HDL," says Michael Miller，director of preventive cardiology at the University of Maryland Medical Center，Baltimore. Questions 7-13 Match torcetrapib，HDLs，statin and CETP with their functions (Questions 8-13)..Write the correct letter A，B，C or D in boxes 8-13 on your answer sheet.NB You may use any letter more than once. 7.It has been administered to over 10,000 subjects in a clinical trial. 8.It could help rid human body of cholesterol. 9.Researchers are yet to find more about it. 10.It was used to reduce the level of cholesterol. 11.According to Kashyap，it might lead to unwanted result if it's blocked. 12.It produced contradictory results in different trials. 13.It could inhibit LDLs.List of choices A.TorcetrapicB.HDLSC.StatinD.CETP
试题分类： 阅读
练习次数：3次
A number of companies use nontraditional benefits and perks to help employees cope with stress.
试题分类： 初级(口语)
练习次数：0次
Student or work?
试题分类： 口语
练习次数：0次
Safety inspection
试题分类： 初级(口语)
练习次数：0次
If you are willing to buy the whole lot once and for all ,we can grant you a discount of 8% on the price.
试题分类： 口语
练习次数：2次
相关题库 更多>
广播电视播音主持业务(笔试) 广播电视基础知识 综合知识
新手指南
会员服务
服务支持
扫一扫，手机做题